Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02007044
Title Ibrutinib With or Without Rituximab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors M.D. Anderson Cancer Center

prolymphocytic leukemia

chronic lymphocytic leukemia/small lymphocytic lymphoma



Ibrutinib + Rituximab

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST